-
Synovus Financial, Gilead Sciences And More On CNBC's 'Final Trades'
09 Jul 2025 12:48 GMT
… Virtus Investment Partners, picked Gilead Sciences, Inc. GILD as his … .
According to recent news, Gilead Sciences and Kymera Therapeutics, Inc. … Price Action:
Synovus Financial shares gained 0.6% to … 41.69 on Tuesday.
Gilead Sciences shares fell 0.6% to close …
-
Fun With Kids: Local breakfast plushies, makerspace at Children’s Museum, free picture book on cancer
20 Jul 2025 08:57 GMT
… Cancer Foundation member Chen Yi shares the story of The Adventure … , a psychiatrist and biopharmaceutical company Gilead Sciences in the United States.
Picture … by BCF in collaboration with Gilead Sciences, involving 93 cancer patients and …
-
Analysts Are Bullish on These Healthcare Stocks: Arcturus Therapeutics (ARCT), Gilead Sciences (GILD)
30 Jun 2025 01:05 GMT
… Arcturus Therapeutics (ARCT – Research Report), Gilead Sciences (GILD – Research Report) and Kymera … Gilead Sciences, with a price target of $126.00. The company’s shares … .
Currently, the analyst consensus on Gilead Sciences is a Moderate Buy with …
-
Wells Fargo Sticks to Their Buy Rating for Gilead Sciences (GILD)
30 Jun 2025 01:05 GMT
… maintained a Buy rating on Gilead Sciences (GILD – Research Report) … .00. The company’s shares closed last Friday at $ … focusing on stocks such as Gilead Sciences, Biogen, and Regeneron. According … maintained a Hold rating on Gilead Sciences (NASDAQ: GILD).
GILD …
-
Why This Looming Supreme Court Decision Could Rattle Gilead Sciences
27 Jun 2025 15:37 GMT
Shares of Gilead Sciences (GILD) rose Friday after the … 109.71.
Gilead Sciences' Big Bet On HIV Prevention
Gilead Sciences is paving … ;
PrEP Drugs Could Be Lucrative
Gilead Sciences announced a $28,218 annual …
-
Gilead Sciences Signs $750M Deal For Cancer Drug With Kymera Therapeutics, Predicts Hit To Its Annual Profit
26 Jun 2025 02:30 GMT
Gilead Sciences, Inc. (GILD) said on Wednesday … 25, 2025 | Source: Stocktwits KYMR shares have risen over 14% this …
-
BMO Capital Keeps Their Buy Rating on Gilead Sciences (GILD)
19 Jun 2025 05:36 GMT
… reiterated a Buy rating on Gilead Sciences (GILD – Research Report) … .00. The company’s shares closed today at $108.00 … addition to BMO Capital, Gilead Sciences also received a Buy from … maintained a Hold rating on Gilead Sciences (NASDAQ: GILD).
GILD market …
-
George Shares Takeaways From IO Trials and AE Management in Pretreated RCC
18 Jun 2025 18:05 GMT
Saby George, MD (Moderator)
Professor of Oncology
Director, Network Clinical Trials
Department of Medicine
Roswell Park Comprehensive Cancer Center
Buffalo, NY
EVENT REGION Northeast
PARTICIPANT LIST Qamar Zaman, MD | Yu-Ning Wong, MD | Naomi B. Haas, MD | …
-
How To Put $100 In Your Retirement Fund Each Month With Gilead Sciences Stock
09 May 2025 12:16 GMT
… $1,200 annually — from Gilead Sciences dividends, your investment value needs … 344, which is around 379 shares at $103.68 each. … month by owning 379 shares of stock. There may … ;s consistent dividend hikes. Gilead Sciences has raised its dividend consecutively …
-
Gilead Sciences Stock Falls as Slumping COVID-19, Cancer Drug Sales Hit Revenue
25 Apr 2025 14:53 GMT
… #47; NurPhoto via Getty Images
Gilead Sciences missed first-quarter revenue estimates … treatments.
Gilead Sciences reduced its full-year profit outlook.
Gilead Sciences (GILD) shares fell Friday … #39;s 4% slide, shares of Gilead Sciences remain up about 11% so …
About
© 1995-2025